Navigation Links
Fate Therapeutics' iPSC Technology Awarded Top Industry Honors for Small Molecule and Protein Reprogramming Breakthroughs
Date:12/21/2009

SAN DIEGO, Dec. 21 /PRNewswire/ -- Fate Therapeutics, Inc. announced today that the Company's iPSC technology platform, developed with Sheng Ding, Ph.D., has been honored as the Top Innovation of 2009 by The Scientist and has received the 2009 North American Technology Innovation Award from Frost & Sullivan. These notable awards recognize Fate Therapeutics for advancing minimally invasive techniques for the reprogramming and differentiation of induced pluripotent stem cells (iPSCs), including the protein-induced reprogramming technologies pioneered by Dr. Ding, associate professor at The Scripps Research Institute and a scientific founder of Fate Therapeutics. Earlier this year, under a research collaboration with Fate Therapeutics and The Scripps Research Institute, Dr. Ding and his team of scientists became the first group to accomplish the extraordinary feat of iPSC generation without genetic manipulation.

"We are honored to receive these recognitions of achievement and thankful for the contributions of our Scientific Founders," said Paul Grayson, president and CEO of Fate Therapeutics. "By building on their pioneering research, we are striving to create an industry admired stem cell biology drug discovery engine for the identification and development of small molecules and biologics to modulate cell fate for therapeutic benefit."

Fate Therapeutics utilizes the most advanced reprogramming and differentiation technologies for generating cell types of interest to elucidate disease biology and identify targets for therapeutic intervention. The Company's protein-based reprogramming platform in combination with its novel small molecule conditions offers a highly efficient, non-viral, non-DNA based m
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
2. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
3. Cell Therapeutics Announces FDAs Oncologic Drugs Advisory Committee to Review Pixantrone for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkins Lymphoma, February 10, 2010
4. Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
5. Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
6. Oxygen Biotherapeutics, Inc. Expands Board of Directors
7. Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign
8. Drug Candidates in Pipeline Offer Potential for Parkinsons Disease Therapeutics Market, Says Frost & Sullivan
9. Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy
10. Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing
11. Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... than a third of reproductive-aged women enrolled in Medicaid, and ... a prescription for an opioid pain medication each year during ... Mortality Weekly Report (MMWR). Opioids are typically ... pain.  They are also found in some prescription cough medications. ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) ... "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with the ... provides an update for shareholders detailing why a "YES" vote ... Dear Shareholders, As we reflect upon the ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a ... insurance policy . , Some types of vehicles cannot be ... newly released blog post to see if their vehicle qualifies for ... are some of the cars that cannot be covered by a ...
(Date:1/22/2015)... State Forestry Institute of Mecklenburg-Vorpommern in Germany ... from GEOSYSTEMS, a dedicated Hexagon Geospatial and Intergraph partner ... Geospatial’s ERDAS APOLLO for cataloging, managing, and ... clouds and documents. This effort will enable the State ...
Breaking Medicine News(10 mins):Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... today announced an agreement with two non-profit organizations ... for rare blood cancers. The cooperative research ... shared commitment to move therapies for rare blood ... treatments can eventually be commercialized. The agreement is ...
... researchers have faced a baffling riddle: how to unravel a disorder ... brain. Now a UCLA study is the ... molecular level, resulting in an autistic brain that differs dramatically in ... online edition of Nature , the findings provide new insight ...
... News) -- A new drug that had shown promise in ... second stoke in someone who,s already had one, a new ... early because the drug, terutroban, showed no extra benefit. ... as effective as aspirin at preventing blood clots, and scientists ...
... Nationwide Children,s have received a grant from the National ... for MPS IIIB that has been shown effective in ... Mucopolysaccharidosis (MPS) IIIB, also known as Sanfilippo Syndrome B, ... the essential enzyme NAGLU. Children with MPS IIIB appear ...
... K. Babayan, MD, chief of the Department of Urology ... the Department of Urology at Boston University School of ... at their annual meeting in Washington, DC, last week ... specialty of urology and the AUA. Babayan received ...
... drink-drivers are more likely to be older, better-educated and ... study by academics at The University of Nottingham found ... triggers in alcohol-related offences committed by women. And ... to face the consequences of their crime can intensify ...
Cached Medicine News:Health News:NIH and non-profits sign research and development agreement 2Health News:Autism changes molecular structure of the brain, UCLA study finds 2Health News:Autism changes molecular structure of the brain, UCLA study finds 3Health News:Study Finds Aspirin Still Best at Preventing 2nd Stroke 2Health News:NIH grant for the move toward clinical trials targeting the lysosomal storage disease MPSIIIB 2Health News:Research study reveals profile for female drunk-drivers 2Health News:Research study reveals profile for female drunk-drivers 3
ICL manipulator, blunt, forked tip...
ICL manipulator with textured hemi-ball tip...
ICL manipulator with textured micro-ball tip....
0.25 mm diameter textured tip with protective guard....
Medicine Products: